Thus MMP-2 and MMP-9 expression in the tissue and body fluids may be of diagnostic, prognostic and predictive value in the detection and/or clinical monitoring of disease progression and therapeutic efficacy in patients with prostate cancer. This evidence concerns the gene MMP9 and prostate carcinoma.